enVVeno Medical (NVNO) Competitors $1.00 +0.03 (+3.09%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$0.99 -0.01 (-1.00%) As of 08/22/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. SNWV, CLPT, TCMD, SMTI, SKIN, BWAY, NPCE, DRTS, CATX, and OMShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Sanuwave Health (SNWV), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Sanara MedTech (SMTI), Beauty Health (SKIN), Brainsway (BWAY), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors Sanuwave Health ClearPoint Neuro Tactile Systems Technology Sanara MedTech Beauty Health Brainsway NeuroPace Alpha Tau Medical Perspective Therapeutics Outset Medical Sanuwave Health (NASDAQ:SNWV) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment. Does the media favor SNWV or NVNO? In the previous week, enVVeno Medical had 8 more articles in the media than Sanuwave Health. MarketBeat recorded 9 mentions for enVVeno Medical and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.00 beat enVVeno Medical's score of -0.40 indicating that Sanuwave Health is being referred to more favorably in the media. Company Overall Sentiment Sanuwave Health Positive enVVeno Medical Neutral Do insiders and institutionals hold more shares of SNWV or NVNO? 42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 16.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, SNWV or NVNO? Sanuwave Health has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Do analysts prefer SNWV or NVNO? Sanuwave Health presently has a consensus price target of $55.00, suggesting a potential upside of 22.22%. Given Sanuwave Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Sanuwave Health is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00enVVeno Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better valuation & earnings, SNWV or NVNO? enVVeno Medical has lower revenue, but higher earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanuwave Health$32.63M11.82-$31.37M-$8.25-5.45enVVeno MedicalN/AN/A-$21.82M-$1.20-0.83 Is SNWV or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to Sanuwave Health's net margin of -97.03%. Sanuwave Health's return on equity of 0.00% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sanuwave Health-97.03% N/A -135.15% enVVeno Medical N/A -57.35%-53.49% SummarySanuwave Health beats enVVeno Medical on 8 of the 15 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.67M$6.88B$5.76B$9.61BDividend YieldN/A1.31%4.41%4.10%P/E Ratio-0.8327.4531.2226.05Price / SalesN/A75.48435.14103.68Price / CashN/A21.3437.7358.48Price / Book0.586.889.536.61Net Income-$21.82M$176.42M$3.26B$265.65M7 Day Performance-79.63%1.45%2.12%2.03%1 Month Performance-80.28%-2.71%2.81%-0.30%1 Year Performance-81.85%9.40%30.62%19.06% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.6898 of 5 stars$1.00+3.1%N/A-81.4%$18.67MN/A-0.8330Analyst DowngradeHigh Trading VolumeSNWVSanuwave Health1.4411 of 5 stars$36.71-4.3%$49.00+33.5%N/A$314.61M$32.63M-4.4540Analyst ForecastGap UpCLPTClearPoint Neuro1.7127 of 5 stars$10.46-6.8%$19.67+88.0%-5.9%$297.38M$31.39M-12.91110TCMDTactile Systems Technology2.4664 of 5 stars$12.86+2.2%$13.50+5.0%+6.2%$286.68M$298.85M20.741,037Positive NewsSMTISanara MedTech2.063 of 5 stars$30.86-2.3%$50.00+62.0%+3.0%$274.72M$97.24M-26.6060News CoverageAnalyst RevisionSKINBeauty Health1.0202 of 5 stars$2.16-1.4%$2.63+21.5%+46.4%$273.93M$334.30M-7.711,030Positive NewsBWAYBrainsway3.1563 of 5 stars$14.47-2.6%$18.00+24.4%+92.2%$273.48M$46.08M55.66120News CoverageShort Interest ↓NPCENeuroPace3.4871 of 5 stars$8.25-2.0%$16.60+101.2%+28.2%$272.91M$79.91M-9.82170Short Interest ↑DRTSAlpha Tau Medical2.7862 of 5 stars$3.12-4.3%$9.00+188.5%+41.7%$264.64MN/A-6.5080News CoverageCATXPerspective Therapeutics1.5594 of 5 stars$3.42-7.3%$12.56+267.1%-75.4%$253.98MN/A0.0070Analyst RevisionOMOutset Medical1.4739 of 5 stars$13.35-2.3%$24.67+84.8%+32.3%$237.23M$113.69M-0.66520Analyst Forecast Related Companies and Tools Related Companies SNWV Alternatives CLPT Alternatives TCMD Alternatives SMTI Alternatives SKIN Alternatives BWAY Alternatives NPCE Alternatives DRTS Alternatives CATX Alternatives OM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access